ajoene has been researched along with benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Antlsperger, DS; Dirsch, VM; Hentze, H; Vollmar, AM | 1 |
| Bai, C; Chen, S; Jiao, Y; Sun, Z; Wang, Y | 1 |
2 other study(ies) available for ajoene and benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone
| Article | Year |
|---|---|
Ajoene, an experimental anti-leukemic drug: mechanism of cell death.
Topics: Amino Acid Chloromethyl Ketones; Antineoplastic Agents, Phytogenic; Apoptosis; bcl-X Protein; Caspase 3; Caspase 8; Caspase 9; Caspases; Cysteine Proteinase Inhibitors; Cytochrome c Group; Disulfides; DNA Fragmentation; DNA, Neoplasm; Enzyme Activation; Enzyme Precursors; Fas Ligand Protein; fas Receptor; Gene Expression Regulation, Leukemic; HL-60 Cells; Humans; Intracellular Membranes; Jurkat Cells; Membrane Glycoproteins; Membrane Potentials; Mitochondria; Neoplasm Proteins; NF-kappa B; Oxidative Stress; Permeability; Plant Extracts; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species; Sulfoxides | 2002 |
ROS-mediated activation of JNK/p38 contributes partially to the pro-apoptotic effect of ajoene on cells of lung adenocarcinoma.
Topics: A549 Cells; Adenocarcinoma; Amino Acid Chloromethyl Ketones; Animals; Apoptosis; Caspase Inhibitors; Caspases; Cell Line; Cell Line, Tumor; Cell Survival; Disulfides; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Inhibitors; Humans; Immunoblotting; JNK Mitogen-Activated Protein Kinases; Lung Neoplasms; Male; Mice, Nude; p38 Mitogen-Activated Protein Kinases; Reactive Oxygen Species; Signal Transduction; Sulfoxides; Time Factors; Xenograft Model Antitumor Assays | 2016 |